|
US5399363A
(en)
*
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
|
AU642066B2
(en)
*
|
1991-01-25 |
1993-10-07 |
Nanosystems L.L.C. |
X-ray contrast compositions useful in medical imaging
|
|
SE470086B
(sv)
*
|
1991-04-23 |
1993-11-08 |
Kabi Pharmacia Ab |
Organspecifik emulsion
|
|
AU660852B2
(en)
*
|
1992-11-25 |
1995-07-06 |
Elan Pharma International Limited |
Method of grinding pharmaceutical substances
|
|
US5298262A
(en)
*
|
1992-12-04 |
1994-03-29 |
Sterling Winthrop Inc. |
Use of ionic cloud point modifiers to prevent particle aggregation during sterilization
|
|
US5346702A
(en)
*
|
1992-12-04 |
1994-09-13 |
Sterling Winthrop Inc. |
Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization
|
|
US5260478A
(en)
*
|
1992-12-08 |
1993-11-09 |
Sterling Winthrop Inc. |
Iodinated aroyloxy carboxamides
|
|
US5340564A
(en)
*
|
1992-12-10 |
1994-08-23 |
Sterling Winthrop Inc. |
Formulations comprising olin 10-G to prevent particle aggregation and increase stability
|
|
US5336507A
(en)
*
|
1992-12-11 |
1994-08-09 |
Sterling Winthrop Inc. |
Use of charged phospholipids to reduce nanoparticle aggregation
|
|
US5429824A
(en)
*
|
1992-12-15 |
1995-07-04 |
Eastman Kodak Company |
Use of tyloxapole as a nanoparticle stabilizer and dispersant
|
|
US5352459A
(en)
*
|
1992-12-16 |
1994-10-04 |
Sterling Winthrop Inc. |
Use of purified surface modifiers to prevent particle aggregation during sterilization
|
|
US5322679A
(en)
*
|
1992-12-16 |
1994-06-21 |
Sterling Winthrop Inc. |
Iodinated aroyloxy esters
|
|
US5346688A
(en)
*
|
1992-12-16 |
1994-09-13 |
Sterling Winthrop Inc. |
Iodinated wetting agents
|
|
US5326552A
(en)
*
|
1992-12-17 |
1994-07-05 |
Sterling Winthrop Inc. |
Formulations for nanoparticulate x-ray blood pool contrast agents using high molecular weight nonionic surfactants
|
|
US6753006B1
(en)
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
|
US5665382A
(en)
*
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of pharmaceutically active agents for in vivo delivery
|
|
US20070117862A1
(en)
*
|
1993-02-22 |
2007-05-24 |
Desai Neil P |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US5498421A
(en)
*
|
1993-02-22 |
1996-03-12 |
Vivorx Pharmaceuticals, Inc. |
Composition useful for in vivo delivery of biologics and methods employing same
|
|
US5650156A
(en)
*
|
1993-02-22 |
1997-07-22 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of nutriceuticals and compositions useful therefor
|
|
US20030133955A1
(en)
*
|
1993-02-22 |
2003-07-17 |
American Bioscience, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
US20030068362A1
(en)
*
|
1993-02-22 |
2003-04-10 |
American Bioscience, Inc. |
Methods and formulations for the delivery of pharmacologically active agents
|
|
GB9303992D0
(en)
*
|
1993-02-26 |
1993-04-14 |
Nycomed Imaging As |
Contrast agents
|
|
US5310537A
(en)
*
|
1993-03-01 |
1994-05-10 |
Sterling Winthrop Inc. |
Compositions of iodoaniline derivatives for visualization of the gastrointestinal tract
|
|
US5330740A
(en)
*
|
1993-03-01 |
1994-07-19 |
Sterling Winthrop Inc. |
Compositions of iodoaniline derivatives in film-forming materials for visualization of the gastrointestinal tract
|
|
US5264610A
(en)
*
|
1993-03-29 |
1993-11-23 |
Sterling Winthrop Inc. |
Iodinated aromatic propanedioates
|
|
US5368837A
(en)
*
|
1994-04-14 |
1994-11-29 |
Sterling Winthrop Inc. |
X-ray contrast compositions containing an organic crystalline X-ray contrast agent and a cellulose derivative
|
|
US5488133A
(en)
*
|
1994-03-10 |
1996-01-30 |
Eastman Kodak Company |
Iodinated aroyloxy ketones
|
|
US5535746A
(en)
*
|
1994-03-29 |
1996-07-16 |
Sterling Winthrop Inc. |
Prefilled syringe for use with power injector
|
|
US5478705A
(en)
*
|
1994-05-25 |
1995-12-26 |
Eastman Kodak Company |
Milling a compound useful in imaging elements using polymeric milling media
|
|
US5500331A
(en)
*
|
1994-05-25 |
1996-03-19 |
Eastman Kodak Company |
Comminution with small particle milling media
|
|
US5718388A
(en)
*
|
1994-05-25 |
1998-02-17 |
Eastman Kodak |
Continuous method of grinding pharmaceutical substances
|
|
US5513803A
(en)
*
|
1994-05-25 |
1996-05-07 |
Eastman Kodak Company |
Continuous media recirculation milling process
|
|
US5567410A
(en)
*
|
1994-06-24 |
1996-10-22 |
The General Hospital Corporation |
Composotions and methods for radiographic imaging
|
|
US5525328A
(en)
*
|
1994-06-24 |
1996-06-11 |
Nanosystems L.L.C. |
Nanoparticulate diagnostic diatrizoxy ester X-ray contrast agents for blood pool and lymphatic system imaging
|
|
WO1996000210A1
(en)
*
|
1994-06-24 |
1996-01-04 |
Nanosystems L.L.C. |
2,4,6-triiodo-5-substituted-amino-isophthalate esters useful as x-ray contrast agents for medical diagnostic imaging
|
|
US5587143A
(en)
*
|
1994-06-28 |
1996-12-24 |
Nanosystems L.L.C. |
Butylene oxide-ethylene oxide block copolymer surfactants as stabilizer coatings for nanoparticle compositions
|
|
US5628981A
(en)
*
|
1994-12-30 |
1997-05-13 |
Nano Systems L.L.C. |
Formulations of oral gastrointestinal diagnostic x-ray contrast agents and oral gastrointestinal therapeutic agents
|
|
US5466440A
(en)
*
|
1994-12-30 |
1995-11-14 |
Eastman Kodak Company |
Formulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable clays
|
|
US5716642A
(en)
*
|
1995-01-10 |
1998-02-10 |
Nano Systems L.L.C. |
Microprecipitation of nanoparticulate pharmaceutical agents using surface active material derived from similar pharmaceutical agents
|
|
US5569448A
(en)
*
|
1995-01-24 |
1996-10-29 |
Nano Systems L.L.C. |
Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions
|
|
US5593657A
(en)
*
|
1995-02-09 |
1997-01-14 |
Nanosystems L.L.C. |
Barium salt formulations stabilized by non-ionic and anionic stabilizers
|
|
US5622938A
(en)
*
|
1995-02-09 |
1997-04-22 |
Nano Systems L.L.C. |
Sugar base surfactant for nanocrystals
|
|
US5500204A
(en)
*
|
1995-02-10 |
1996-03-19 |
Eastman Kodak Company |
Nanoparticulate diagnostic dimers as x-ray contrast agents for blood pool and lymphatic system imaging
|
|
WO1996025181A1
(en)
*
|
1995-02-14 |
1996-08-22 |
Nanosystems L.L.C. |
Process of preparing lymphography contrast agents
|
|
US5543133A
(en)
*
|
1995-02-14 |
1996-08-06 |
Nanosystems L.L.C. |
Process of preparing x-ray contrast compositions containing nanoparticles
|
|
EP0810853B1
(en)
*
|
1995-02-24 |
2004-08-25 |
Elan Pharma International Limited |
Aerosols containing nanoparticle dispersions
|
|
US5472683A
(en)
*
|
1995-03-09 |
1995-12-05 |
Eastman Kodak Company |
Nanoparticulate diagnostic mixed carbamic anhydrides as X-ray contrast agents for blood pool and lymphatic system imaging
|
|
AU5187696A
(en)
*
|
1995-03-09 |
1996-10-02 |
Nanosystems L.L.C. |
Nanoparticulate diagnostic triiodo benzoate derivatives as x-ray contrast agents for blood pool and lymphatic system imaging
|
|
US5573749A
(en)
*
|
1995-03-09 |
1996-11-12 |
Nano Systems L.L.C. |
Nanoparticulate diagnostic mixed carboxylic anhydrides as X-ray contrast agents for blood pool and lymphatic system imaging
|
|
US5643552A
(en)
*
|
1995-03-09 |
1997-07-01 |
Nanosystems L.L.C. |
Nanoparticulate diagnostic mixed carbonic anhydrides as x-ray contrast agents for blood pool and lymphatic system imaging
|
|
US5521218A
(en)
*
|
1995-05-15 |
1996-05-28 |
Nanosystems L.L.C. |
Nanoparticulate iodipamide derivatives for use as x-ray contrast agents
|
|
US5603916A
(en)
*
|
1995-05-22 |
1997-02-18 |
Nano Systems L.L.C. |
3 5-bis alkanoyl amino-2 4 6-triiodobenzyl esters
|
|
US5573750A
(en)
*
|
1995-05-22 |
1996-11-12 |
Nanosystems L.L.C. |
Diagnostic imaging x-ray contrast agents
|
|
US5834025A
(en)
|
1995-09-29 |
1998-11-10 |
Nanosystems L.L.C. |
Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
|
|
US5662279A
(en)
*
|
1995-12-05 |
1997-09-02 |
Eastman Kodak Company |
Process for milling and media separation
|
|
US6368586B1
(en)
|
1996-01-26 |
2002-04-09 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers
|
|
WO1997030459A1
(en)
*
|
1996-02-14 |
1997-08-21 |
Philips Electronics N.V. |
X-ray examination apparatus with x-ray filter
|
|
GB9603547D0
(en)
*
|
1996-02-20 |
1996-04-17 |
Nycomed Imaging As |
Contrast media
|
|
PT101919B
(pt)
*
|
1996-09-30 |
2000-01-31 |
Hovione Sociedade Quimica Sa |
Um processo para a purificacao de tohexol
|
|
US8137684B2
(en)
|
1996-10-01 |
2012-03-20 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US20050004049A1
(en)
*
|
1997-03-11 |
2005-01-06 |
Elan Pharma International Limited |
Novel griseofulvin compositions
|
|
WO1998048847A1
(en)
*
|
1997-04-25 |
1998-11-05 |
Nycomed Imaging As |
Nanoparticle composition containing iodinated x-ray contrast agent as stabilizer for thermal sterilization
|
|
GB9710604D0
(en)
*
|
1997-05-22 |
1997-07-16 |
Nycomed Imaging As |
Contrast media
|
|
KR100904931B1
(ko)
*
|
1997-06-27 |
2009-06-29 |
아브락시스 바이오사이언스, 엘엘씨 |
나노 입자 및 그의 제조 방법
|
|
UA72189C2
(uk)
|
1997-11-17 |
2005-02-15 |
Янссен Фармацевтика Н.В. |
Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
|
|
DE69920425T2
(de)
*
|
1998-04-09 |
2005-09-29 |
Amersham Health As |
Verwendung von teilchenförmigen kontrastmitteln in der diagnostischen bilderzeugung zur untersuchung physiologischer parameter
|
|
US20080213378A1
(en)
*
|
1998-10-01 |
2008-09-04 |
Elan Pharma International, Ltd. |
Nanoparticulate statin formulations and novel statin combinations
|
|
EP2266542A3
(en)
*
|
1998-10-01 |
2013-07-31 |
Elan Pharma International Limited |
Controlled release nanoparticulate compositions
|
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
|
US8236352B2
(en)
*
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
|
DK1126826T6
(en)
*
|
1998-11-02 |
2019-06-24 |
Alkermes Pharma Ireland Ltd |
Multiparticulate modified release of methylphenidate
|
|
US20070160675A1
(en)
*
|
1998-11-02 |
2007-07-12 |
Elan Corporation, Plc |
Nanoparticulate and controlled release compositions comprising a cephalosporin
|
|
US6375986B1
(en)
|
2000-09-21 |
2002-04-23 |
Elan Pharma International Ltd. |
Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
|
|
US20040141925A1
(en)
*
|
1998-11-12 |
2004-07-22 |
Elan Pharma International Ltd. |
Novel triamcinolone compositions
|
|
US7521068B2
(en)
*
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
|
US6969529B2
(en)
*
|
2000-09-21 |
2005-11-29 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
|
|
US6132044A
(en)
*
|
1998-11-20 |
2000-10-17 |
Luxottica Leasing S.P.A |
Filter for a special purpose lens and method of making filter
|
|
US6203778B1
(en)
*
|
1998-12-08 |
2001-03-20 |
The Regents Of The University Of California |
Particulate radiopaque contrast agent for diagnostic imaging and microvascular characterization
|
|
RU2155072C1
(ru)
*
|
1999-03-09 |
2000-08-27 |
Алтайский государственный медицинский университет |
Способ непрямой лимфографии внутригрудных лимфатических узлов в эксперименте
|
|
US20090104273A1
(en)
*
|
1999-06-22 |
2009-04-23 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
|
US20040115134A1
(en)
*
|
1999-06-22 |
2004-06-17 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
|
US20030203884A1
(en)
*
|
1999-11-09 |
2003-10-30 |
Pharmacia Corporation |
Methods for the treatment or prophylaxis of aldosterone-mediated pathogenic effects in a subject using an epoxy-steroidal aldosterone antagonist
|
|
US20030096798A1
(en)
*
|
1999-11-09 |
2003-05-22 |
Williams Gordon H. |
Methods for the treatment or prophylaxis of aldosterone-mediated pathogenic effects in a subject using an epoxy-steroidal aldosterone antagonist
|
|
AU5967101A
(en)
|
2000-05-10 |
2001-11-20 |
Rtp Pharma Inc |
Media milling
|
|
US6316029B1
(en)
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
|
US20040156872A1
(en)
*
|
2000-05-18 |
2004-08-12 |
Elan Pharma International Ltd. |
Novel nimesulide compositions
|
|
US6716829B2
(en)
|
2000-07-27 |
2004-04-06 |
Pharmacia Corporation |
Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
|
|
JP2004511435A
(ja)
*
|
2000-07-27 |
2004-04-15 |
ファルマシア・コーポレーション |
うっ血性心不全の処置のための、エポキシ−ステロイド型アルドステロン拮抗薬とβ−アドレナリン作動性拮抗薬の併用療法
|
|
DK1313485T3
(da)
*
|
2000-08-28 |
2005-12-27 |
Pharmacia Corp |
Anvendelse af en aldosteronreceptorantagonist til forbedring af kognitiv funktion
|
|
AU8847101A
(en)
|
2000-08-31 |
2002-03-13 |
Rtp Pharma Inc |
Milled particles
|
|
US7198795B2
(en)
*
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
|
US7276249B2
(en)
*
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
US20030224058A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
US7998507B2
(en)
*
|
2000-09-21 |
2011-08-16 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
|
|
US20080241070A1
(en)
*
|
2000-09-21 |
2008-10-02 |
Elan Pharma International Ltd. |
Fenofibrate dosage forms
|
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
|
US20050048126A1
(en)
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
|
US20040256749A1
(en)
*
|
2000-12-22 |
2004-12-23 |
Mahesh Chaubal |
Process for production of essentially solvent-free small particles
|
|
US7037528B2
(en)
|
2000-12-22 |
2006-05-02 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
|
US7193084B2
(en)
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
|
US20030072807A1
(en)
*
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
|
US6951656B2
(en)
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US6977085B2
(en)
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
|
US20040022862A1
(en)
*
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
|
US7071181B2
(en)
|
2001-01-26 |
2006-07-04 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
|
|
SI1413331T1
(sl)
|
2001-01-26 |
2008-02-29 |
Schering Corp |
Kombinacije fenofibrata peroksisomskega proliferator aktivirajocega receptorja (PPAR) z ezetimib zaviralcem absorpcije sterola za vaskularne indikacije
|
|
JP4711600B2
(ja)
|
2001-01-26 |
2011-06-29 |
シェーリング コーポレイション |
シトステロール血症の処置のための置換アゼチジノン化合物の使用
|
|
BR0208626A
(pt)
|
2001-04-03 |
2004-03-09 |
Schering Corp |
Composição antifúngica com biodisponibilidade intensificada
|
|
RU2217052C2
(ru)
*
|
2001-06-01 |
2003-11-27 |
Драцкий Сергей Иванович |
Способ определения подвижности почки у детей
|
|
US6976647B2
(en)
*
|
2001-06-05 |
2005-12-20 |
Elan Pharma International, Limited |
System and method for milling materials
|
|
US20030087308A1
(en)
*
|
2001-06-22 |
2003-05-08 |
Elan Pharma International Limited |
Method for high through put screening using a small scale mill or microfluidics
|
|
US20030220310A1
(en)
*
|
2001-07-27 |
2003-11-27 |
Schuh Joseph R. |
Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure
|
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
|
ES2280582T3
(es)
*
|
2001-09-19 |
2007-09-16 |
Elan Pharma International Limited |
Formulaciones de insulina en nanoparticulas.
|
|
ATE411018T1
(de)
*
|
2001-09-21 |
2008-10-15 |
Schering Corp |
Verfahren zur behandlung oder verhinderung von vaskulärer entzündung mit sterol-absorbierungs- inhibitor(en)
|
|
US7132415B2
(en)
|
2001-09-21 |
2006-11-07 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors
|
|
US7053080B2
(en)
|
2001-09-21 |
2006-05-30 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
|
|
US20060003012A9
(en)
*
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
|
CN1558755A
(zh)
|
2001-09-26 |
2004-12-29 |
���ع��ʹ�˾ |
通过分散和除去溶剂或液相制备亚微米大小的纳米颗粒
|
|
EP1443912B1
(en)
*
|
2001-10-12 |
2007-08-29 |
Elan Pharma International Limited |
Compositions having a combination of immediate release and controlled release characteristics
|
|
US7112340B2
(en)
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
|
WO2003039601A1
(en)
*
|
2001-11-07 |
2003-05-15 |
Imcor Pharmaceutical Company |
Methods for vascular imaging using nanoparticulate contrast agents
|
|
US20030129242A1
(en)
*
|
2002-01-04 |
2003-07-10 |
Bosch H. William |
Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
|
|
US20040101566A1
(en)
*
|
2002-02-04 |
2004-05-27 |
Elan Pharma International Limited |
Novel benzoyl peroxide compositions
|
|
JP4598399B2
(ja)
*
|
2002-02-04 |
2010-12-15 |
エラン ファーマ インターナショナル，リミティド |
表面安定剤としてリゾチームを有するナノ粒子組成物
|
|
ATE343376T1
(de)
*
|
2002-03-20 |
2006-11-15 |
Elan Pharma Int Ltd |
Nanopartikelzusammensetzungen von angiogeneseinhibitoren
|
|
JP2005526095A
(ja)
*
|
2002-03-20 |
2005-09-02 |
エラン ファーマ インターナショナル，リミティド |
脆砕性の低い急速溶解投与剤型
|
|
US20080220075A1
(en)
*
|
2002-03-20 |
2008-09-11 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
US20040076586A1
(en)
*
|
2002-03-28 |
2004-04-22 |
Reinhard Koening |
Compositions and methods for delivering pharmaceutically active agents using nanoparticulates
|
|
US20040105889A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
|
ATE539737T1
(de)
|
2002-04-12 |
2012-01-15 |
Alkermes Pharma Ireland Ltd |
Nanopartikuläre megestrol- formulierungen
|
|
US20100226989A1
(en)
*
|
2002-04-12 |
2010-09-09 |
Elan Pharma International, Limited |
Nanoparticulate megestrol formulations
|
|
US7101576B2
(en)
*
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
|
US9101540B2
(en)
|
2002-04-12 |
2015-08-11 |
Alkermes Pharma Ireland Limited |
Nanoparticulate megestrol formulations
|
|
AU2003234452A1
(en)
*
|
2002-05-06 |
2003-11-11 |
Elan Pharma International Ltd. |
Nanoparticulate nystatin formulations
|
|
US20070264348A1
(en)
*
|
2002-05-24 |
2007-11-15 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
WO2003103632A1
(en)
*
|
2002-06-10 |
2003-12-18 |
Elan Pharma International, Ltd. |
Nanoparticulate polycosanol formulations and novel polycosanol combinations
|
|
CA2492488A1
(en)
*
|
2002-07-16 |
2004-01-22 |
Elan Pharma International, Ltd. |
Liquid dosage compositions of stable nanoparticulate active agents
|
|
ES2355723T3
(es)
*
|
2002-09-11 |
2011-03-30 |
Elan Pharma International Limited |
Composiciones de agente activo en nanopartículas estabilizadas en gel.
|
|
US20040054413A1
(en)
*
|
2002-09-16 |
2004-03-18 |
Howmedica Osteonics Corp. |
Radiovisible hydrogel intervertebral disc nucleus
|
|
WO2004032980A1
(en)
*
|
2002-10-04 |
2004-04-22 |
Elan Pharma International Limited |
Gamma irradiation of solid nanoparticulate active agents
|
|
CA2504878A1
(en)
*
|
2002-11-06 |
2004-05-27 |
Schering Corporation |
Cholesterol absorption inhibitors for the treatment of demyelination
|
|
ATE514418T1
(de)
*
|
2002-11-12 |
2011-07-15 |
Elan Pharma Int Ltd |
Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan
|
|
US20040173696A1
(en)
*
|
2002-12-17 |
2004-09-09 |
Elan Pharma International Ltd. |
Milling microgram quantities of nanoparticulate candidate compounds
|
|
CA2513064C
(en)
*
|
2003-01-31 |
2009-11-10 |
Elan Pharma International, Ltd. |
Nanoparticulate topiramate formulations
|
|
US20040208833A1
(en)
*
|
2003-02-04 |
2004-10-21 |
Elan Pharma International Ltd. |
Novel fluticasone formulations
|
|
US20100297252A1
(en)
*
|
2003-03-03 |
2010-11-25 |
Elan Pharma International Ltd. |
Nanoparticulate meloxicam formulations
|
|
US8512727B2
(en)
*
|
2003-03-03 |
2013-08-20 |
Alkermes Pharma Ireland Limited |
Nanoparticulate meloxicam formulations
|
|
CN100439361C
(zh)
|
2003-03-07 |
2008-12-03 |
先灵公司 |
取代的2-吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
|
|
US7459442B2
(en)
|
2003-03-07 |
2008-12-02 |
Schering Corporation |
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
|
|
CN1756755A
(zh)
|
2003-03-07 |
2006-04-05 |
先灵公司 |
取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
|
|
JP4589919B2
(ja)
|
2003-03-07 |
2010-12-01 |
シェーリング コーポレイション |
高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用
|
|
WO2004098649A2
(en)
*
|
2003-05-06 |
2004-11-18 |
Philips Intellectual Property & Standards Gmbh |
Apparatus and method for examining an object by means of elastically scattered x-ray radiation and contrast agent
|
|
CA2523035C
(en)
*
|
2003-05-22 |
2011-04-26 |
Elan Pharma International Ltd. |
Sterilization of dispersions of nanoparticulate active agents with gamma radiation
|
|
ES2318330T3
(es)
*
|
2003-08-08 |
2009-05-01 |
Elan Pharma International Limited |
Nuevas composiciones de metaxalona.
|
|
CA2544627A1
(en)
*
|
2003-11-05 |
2005-05-19 |
Elan Pharma International Ltd. |
Nanoparticulate compositions having a peptide as a surface stabilizer
|
|
EP1688169A4
(en)
*
|
2003-11-28 |
2008-10-01 |
Mitsubishi Chem Corp |
PROCESS FOR PRODUCING FINE PARTICLES OF AN ORGANIC COMPOUND
|
|
WO2006026504A2
(en)
*
|
2004-08-27 |
2006-03-09 |
Spherics, Inc. |
Mucoadhesive oral formulations of high permeability, high solubility drugs
|
|
WO2006028074A1
(ja)
*
|
2004-09-07 |
2006-03-16 |
Mitsubishi Chemical Corporation |
微粒子化された物質の製造方法および微粒子化された物質
|
|
US20090155331A1
(en)
*
|
2005-11-16 |
2009-06-18 |
Elan Pharma International Limited |
Injectable nanoparticulate olanzapine formulations
|
|
US7910577B2
(en)
*
|
2004-11-16 |
2011-03-22 |
Elan Pharma International Limited |
Injectable nanoparticulate olanzapine formulations
|
|
UA89513C2
(uk)
*
|
2004-12-03 |
2010-02-10 |
Элан Фарма Интернешнл Лтд. |
Стабільна композиція з наночастинок ралоксифену гідрохлориду
|
|
SG161203A1
(en)
*
|
2004-12-15 |
2010-05-27 |
Elan Pharma Int Ltd |
Nanoparticulate tacrolimus formulations
|
|
US20060159767A1
(en)
*
|
2004-12-22 |
2006-07-20 |
Elan Pharma International Limited |
Nanoparticulate bicalutamide formulations
|
|
CA2594332A1
(en)
*
|
2005-01-06 |
2006-07-13 |
Elan Pharma International Ltd. |
Nanoparticulate candesartan formulations
|
|
EA013433B1
(ru)
*
|
2005-02-15 |
2010-04-30 |
Элан Фарма Интернэшнл Лтд. |
Аэрозольные и впрыскиваемые рецептуры лекарственных препаратов бензодиазепина, состоящего из наночастиц
|
|
US20080254114A1
(en)
*
|
2005-03-03 |
2008-10-16 |
Elan Corporation Plc |
Controlled Release Compositions Comprising Heterocyclic Amide Derivative Nanoparticles
|
|
US20060204588A1
(en)
*
|
2005-03-10 |
2006-09-14 |
Elan Pharma International Limited |
Formulations of a nanoparticulate finasteride, dutasteride or tamsulosin hydrochloride, and mixtures thereof
|
|
US20070065374A1
(en)
*
|
2005-03-16 |
2007-03-22 |
Elan Pharma International Limited |
Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations
|
|
EA200701997A1
(ru)
*
|
2005-03-17 |
2008-02-28 |
Элан Фарма Интернэшнл Лтд. |
Композиция из наночастиц бисфосфоната
|
|
AU2006226887A1
(en)
*
|
2005-03-23 |
2006-09-28 |
Elan Pharma International Limited |
Nanoparticulate corticosteroid and antihistamine formulations
|
|
US8003079B2
(en)
*
|
2005-04-05 |
2011-08-23 |
Bar-Ilan University |
Core and core-shell nanoparticles containing iodine for X-ray imaging
|
|
US20060246141A1
(en)
*
|
2005-04-12 |
2006-11-02 |
Elan Pharma International, Limited |
Nanoparticulate lipase inhibitor formulations
|
|
WO2006110802A1
(en)
*
|
2005-04-12 |
2006-10-19 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising cyclosporine
|
|
BRPI0607537A2
(pt)
*
|
2005-04-12 |
2009-09-15 |
Elan Pharma Int Ltd |
formulações de derivado de quinazolina nanoparticulado
|
|
US20110064803A1
(en)
*
|
2005-05-10 |
2011-03-17 |
Elan Pharma International Limited. |
Nanoparticulate and controlled release compositions comprising vitamin k2
|
|
EP1888037A2
(en)
*
|
2005-05-10 |
2008-02-20 |
Elan Pharma International Limited |
Nanoparticulate clopidogrel formulations
|
|
MX2007014363A
(es)
*
|
2005-05-16 |
2009-04-15 |
Elan Pharma Int Ltd |
Composiciones de liberacion controlada y en forma de nanoparticulas que comprenden una cefalosporina.
|
|
US20100028439A1
(en)
*
|
2005-05-23 |
2010-02-04 |
Elan Pharma International Limited |
Nanoparticulate stabilized anti-hypertensive compositions
|
|
CN101232870A
(zh)
*
|
2005-06-03 |
2008-07-30 |
伊兰制药国际有限公司 |
纳米微粒甲磺酸伊马替尼制剂
|
|
US20060292214A1
(en)
*
|
2005-06-03 |
2006-12-28 |
Elan Pharma International Limited |
Nanoparticulate acetaminophen formulations
|
|
WO2006133045A1
(en)
*
|
2005-06-03 |
2006-12-14 |
Elan Pharma International, Limited |
Nanoparticulate benidipine compositions
|
|
EP1954253A4
(en)
|
2005-06-08 |
2011-07-27 |
Elan Pharma Int Ltd |
NANOTEILIC AND CONTROLLED RELEASED COMPOSITIONS WITH CEFDITORS
|
|
EP1898882B1
(en)
*
|
2005-06-09 |
2009-10-28 |
Elan Pharma International Limited |
Nanoparticulate ebastine formulations
|
|
CN101237868A
(zh)
*
|
2005-06-13 |
2008-08-06 |
伊兰制药国际有限公司 |
纳米粒氯吡格雷和阿司匹林组合制剂
|
|
US20060280786A1
(en)
*
|
2005-06-14 |
2006-12-14 |
Rabinow Barrett E |
Pharmaceutical formulations for minimizing drug-drug interactions
|
|
US20060280787A1
(en)
*
|
2005-06-14 |
2006-12-14 |
Baxter International Inc. |
Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
|
|
JP2008543862A
(ja)
*
|
2005-06-15 |
2008-12-04 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子アゼルニジピン製剤
|
|
GB0512666D0
(en)
*
|
2005-06-22 |
2005-07-27 |
Univ Loughborough |
Method for concentrating nanosuspensions
|
|
US20090180964A1
(en)
*
|
2005-06-24 |
2009-07-16 |
Rao Papineni |
Transmucosal delivery of optical, spect, multimodal,drug or biological cargo laden nanoparticle(s) in small animals or humans
|
|
ES2369928T3
(es)
*
|
2005-06-29 |
2011-12-09 |
Dsm Ip Assets B.V. |
Nanopartículas de isoflavonas y su utilización.
|
|
CA2614412A1
(en)
*
|
2005-07-07 |
2007-01-18 |
Elan Pharma International, Limited |
Nanoparticulate clarithromycin formulations
|
|
GB0516549D0
(en)
*
|
2005-08-12 |
2005-09-21 |
Sulaiman Brian |
Milling system
|
|
WO2007033239A2
(en)
*
|
2005-09-13 |
2007-03-22 |
Elan Pharma International, Limited |
Nanoparticulate tadalafil formulations
|
|
EP1933814A2
(en)
|
2005-09-15 |
2008-06-25 |
Elan Pharma International Limited |
Nanoparticulate aripiprazole formulations
|
|
CA2628630A1
(en)
*
|
2005-11-15 |
2007-05-24 |
Baxter International Inc. |
Compositions of lipoxygenase inhibitors
|
|
CN101583620B
(zh)
|
2005-11-28 |
2016-08-17 |
马里纳斯医药公司 |
加奈索酮组合物及其制备和使用方法
|
|
US7407647B2
(en)
*
|
2005-12-07 |
2008-08-05 |
Cordis Corporation |
Organic radiographic contrasting agents for medical devices
|
|
US20070134163A1
(en)
*
|
2005-12-13 |
2007-06-14 |
Zhao Jonathon Z |
Radiographic contrasting agents and radio-opaque polymeric materials for medical devices
|
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
|
MX2008015275A
(es)
*
|
2006-05-30 |
2009-02-06 |
Elan Pharma Int Ltd |
Formulaciones de posaconazol en nanoparticulas.
|
|
US20080213374A1
(en)
*
|
2006-07-10 |
2008-09-04 |
Elan Pharma International Limited |
Nanoparticulate sorafenib formulations
|
|
DE102006042729A1
(de)
*
|
2006-09-12 |
2008-03-27 |
Siemens Ag |
Verfahren zum Erzeugen eines Röntgenbildes
|
|
WO2008080047A2
(en)
*
|
2006-12-23 |
2008-07-03 |
Baxter International Inc. |
Magnetic separation of fine particles from compositions
|
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
|
US20080293814A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Deepak Tiwari |
Concentrate esmolol
|
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
|
US20090238867A1
(en)
*
|
2007-12-13 |
2009-09-24 |
Scott Jenkins |
Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
|
|
JP2011520779A
(ja)
*
|
2008-03-21 |
2011-07-21 |
エラン・ファルマ・インターナショナル・リミテッド |
イマチニブの部位特異的送達のための組成物および使用の方法
|
|
US20090311335A1
(en)
*
|
2008-06-12 |
2009-12-17 |
Scott Jenkins |
Combination of a triptan and an nsaid
|
|
US20100092390A1
(en)
*
|
2008-10-09 |
2010-04-15 |
President And Fellows Of Harvard College |
Methods for Making Particles Having Long Spin-Lattice Relaxation Times
|
|
KR101130737B1
(ko)
*
|
2008-12-24 |
2012-03-28 |
경북대학교 산학협력단 |
방사성 세포 표지자
|
|
WO2010099508A1
(en)
|
2009-02-26 |
2010-09-02 |
Theraquest Biosciences, Inc. |
Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
|
|
EP2253306A1
(en)
|
2009-05-18 |
2010-11-24 |
Royal College of Surgeons in Ireland |
Orodispersible dosage forms containing solid drug dispersions
|
|
FR2945950A1
(fr)
|
2009-05-27 |
2010-12-03 |
Elan Pharma Int Ltd |
Compositions de nanoparticules anticancereuses et procedes pour les preparer
|
|
CA2763456C
(en)
|
2009-05-27 |
2017-10-24 |
Alkermes Pharma Ireland Limited |
Reduction of flake-like aggregation in nanoparticulate active agent compositions
|
|
PL2952191T3
(pl)
|
2009-06-12 |
2019-02-28 |
Sunovion Pharmaceuticals Inc. |
Apomorfina w postaci do podawania podjęzykowego
|
|
RU2545784C2
(ru)
|
2009-06-19 |
2015-04-10 |
Наноформ Хунгари Лтд. |
Наноструктурированное основание силденафила, его фармацевтически приемлемые соли и со-кристаллы, их композиции, способ их получения и содержащие их фармацевтические композиции
|
|
EA031156B1
(ru)
|
2010-12-16 |
2018-11-30 |
Суновион Фармасьютикалз Инк. |
Сублингвальные пленки
|
|
CN107709344B
(zh)
|
2015-05-01 |
2022-07-15 |
共晶制药股份有限公司 |
用于治疗黄病毒科病毒和癌症的核苷类似物
|
|
WO2016205334A1
(en)
|
2015-06-16 |
2016-12-22 |
Vascular Strategies Llc |
Drug delivery and imaging chemical conjugate, formulations and methods of use thereof
|
|
WO2020039374A1
(en)
|
2018-08-21 |
2020-02-27 |
Chevron U.S.A. Inc. |
Catalytic reforming process and system for making aromatic hydrocarbons
|
|
WO2020060786A1
(en)
|
2018-09-17 |
2020-03-26 |
Chemence Medical, Inc. |
Stable compositions composed of a radiopaque agent and cyanoacrylate monomer and applications thereof
|
|
EP3980400B1
(en)
|
2019-06-05 |
2025-08-06 |
Emory University |
Peptidomimetics for the treatment of coronavirus and picornavirus infections
|
|
JP2024505153A
(ja)
*
|
2021-01-12 |
2024-02-05 |
ボストン サイエンティフィック サイムド，インコーポレイテッド |
放射線造影特性を有するヨウ素化合物
|
|
CN117280200A
(zh)
*
|
2021-05-06 |
2023-12-22 |
株式会社理学 |
X射线造影剂和x射线图像的取得方法
|